RESLIZUMAB
Total Payments
$126,122
Transactions
363
Doctors
220
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $126,122 | 363 | 220 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $58,675 | 14 | 46.5% |
| Food and Beverage | $34,849 | 241 | 27.6% |
| Travel and Lodging | $32,598 | 108 | 25.8% |
Top Doctors Receiving Payments for RESLIZUMAB — Page 9
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Allergy | Twin Falls, ID | $27.95 | 1 |
| Robert Hylander | — | Moses Lake, WA | $27.95 | 1 |
| , MD | Allergy & Immunology | Spokane, WA | $27.95 | 1 |
| , MD | Allergy & Immunology | Spokane, WA | $27.95 | 1 |
| , M.D | Specialist | Austin, TX | $27.95 | 1 |
| , MD | Allergy & Immunology | Missoula, MT | $27.95 | 1 |
| , M.D | Specialist | Kissimmee, FL | $20.65 | 1 |
| , MD | Allergy & Immunology | Saint Petersburg, FL | $20.65 | 1 |
| , MD | Allergy & Immunology | Marshfield, WI | $20.65 | 1 |
| , MD | Specialist | Portland, OR | $20.65 | 1 |
| , M.D | Allergy | Long Beach, CA | $20.65 | 1 |
| , MD | Allergy & Immunology | Eureka, CA | $20.65 | 1 |
| , M.D | Otolaryngology | San Juan, PR | $20.65 | 1 |
| , MD | Specialist | Pasadena, CA | $20.65 | 1 |
| , MD, MS | Allergy & Immunology | Arcadia, CA | $20.65 | 1 |
| , M.D | Internal Medicine | Brea, CA | $20.65 | 1 |
| , M.D | Pediatrics | Mission Viejo, CA | $20.65 | 1 |
| , M.D | Allergy & Immunology | Vista, CA | $20.65 | 1 |
| , D.O | Allergy | Orange Park, FL | $20.65 | 1 |
| , M.D | Pediatrics | San Bernardino, CA | $20.65 | 1 |
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $126,122
Product Information
- Type Drug
- Total Payments $126,122
- Total Doctors 220
- Transactions 363
About RESLIZUMAB
RESLIZUMAB is a drug associated with $126,122 in payments to 220 healthcare providers, recorded across 363 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2017 to 2017. In 2017, $126,122 was paid across 363 transactions to 220 doctors.
The most common payment nature for RESLIZUMAB is "Consulting Fee" ($58,675, 46.5% of total).